{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T19:54:19Z","timestamp":1721937259738},"reference-count":140,"publisher":"Informa UK Limited","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia &amp; Lymphoma"],"published-print":{"date-parts":[[2004,5]]},"DOI":"10.1080\/10428190310001593201","type":"journal-article","created":{"date-parts":[[2004,3,9]],"date-time":"2004-03-09T16:40:39Z","timestamp":1078850439000},"page":"857-871","source":"Crossref","is-referenced-by-count":7,"title":["Heterogeneity in the Multiple Myeloma Tumor Clone"],"prefix":"10.1080","volume":"45","author":[{"given":"Jeroen EJ","family":"Guikema","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sjoerd","family":"Hovenga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edo","family":"Vellenga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolaas A","family":"Bos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2009,8,3]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199607113350204"},{"key":"CIT0002","first-page":"2154 \u2014 2161","volume":"99","author":"Medina F.","year":"2002","journal-title":"\"The heterogeneity shown by human plasma cells from tonsil, blood, and bone marrow reveals graded stages of increasing maturity, but local profiles of adhesion molecule expression\", Blood"},{"key":"CIT0003","first-page":"439","volume":"22","author":"Kurabayashi H.","year":"1998","journal-title":"\"Clinical analysis of the prognostic value of ultrastructural abnormalities of plasma cells in patients with multiple myeloma\", Ultrastructural Pathology"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1982.tb02791.x"},{"key":"CIT0005","first-page":"1072 \u2014 1079","volume":"63","author":"Fritz E.","year":"1984","journal-title":"\"Prognostic relevance of cellular morphology in multiple myeloma\", Blood"},{"key":"CIT0006","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1182\/blood.V65.2.305.305","author":"Greipp P.R.","year":"1985","journal-title":"Blood"},{"key":"CIT0007","first-page":"1060 \u2014 1065","volume":"60","author":"Carter A.","year":"1987","journal-title":"\"Prognostic significance of plasma cell morphology in multiple myeloma\", Cancer"},{"key":"CIT0008","first-page":"93","author":"Pasqualetti P.","year":"1991","journal-title":"Panminerva Medica"},{"key":"CIT0009","first-page":"2501 \u2014 2507","volume":"91","author":"Greipp P.R.","year":"1998","journal-title":"Eastern Cooperative Oncology Group (ECOG) myelo-ma trial E9486 report by the ECOG Myeloma Laboratory Group\", Blood"},{"key":"CIT0010","first-page":"1551 \u2014 1557","volume":"17","author":"Rajkumar S.V.","year":"1999","journal-title":"\"Plasmablastic morphology is an independent predictor of poor survival after autologous stem-cell transplantation for multiple myeloma\", Journal of Clinical Oncology"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1016\/S0145-2126(99)00132-0"},{"key":"CIT0012","first-page":"2326","volume":"80","author":"Bakkus M.H.","year":"1992","journal-title":"\"Evidence that multiple myeloma Ig heavy chain VDJ genes contain somatic mutations but show no intraclonal variation\", Blood"},{"key":"CIT0013","first-page":"2487 \u2014 2497","volume":"155","author":"Vescio R.A.","year":"1995","journal-title":"\"Myeloma Ig heavy chain V region sequences reveal prior antigenic selection and marked somatic mutation but no intraclonal diversity\", Journal of Immunology"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1990.00040031693017"},{"key":"CIT0015","first-page":"773","volume":"90","author":"Irish A.B.","year":"1997","journal-title":"\"Presenta-tion and survival of patients with severe renal failure and myeloma\", QJM"},{"key":"CIT0016","first-page":"209","volume":"182","author":"MacLennan I.C","year":"1992","journal-title":"\"In which cells does neoplastic transfor-mation occur in myelomatosis?\", Current Topics in Microbiology and Immunology"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-08-2436"},{"key":"CIT0018","first-page":"2501 \u20142506","volume":"3","author":"Juge-Morineau N.","year":"1997","journal-title":"\"Immunoglobulins D and M multiple myeloma variants are heavily mutated\", Clinical Cancer Research"},{"key":"CIT0019","first-page":"94, 1070\u2014 1076","author":"Sahota S.S.","year":"1999","journal-title":"Blood"},{"key":"CIT0020","first-page":"187, 1169 \u2014 117","author":"Arpin C.","year":"1998","journal-title":"Journal of Experimental Medicine"},{"key":"CIT0021","first-page":"119","author":"Fine J.M.","year":"1974","journal-title":"Biomedicine"},{"key":"CIT0022","first-page":"471 \u2014475","volume":"33","author":"Fibbe W.E.","year":"1984","journal-title":"a study of 21 cases\", Scandinavian Journal of Haematol-ogy"},{"key":"CIT0023","first-page":"1358","volume":"16","author":"van der Burg M.","year":"2002","journal-title":"\"Biased Iglambda expression in hypermutated IgD multiple myelomas does not result from receptor revision\", Leukemia"},{"key":"CIT0024","first-page":"842","volume":"36","author":"Dune B.G.","year":"1975","journal-title":"Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival\", Cancer"},{"key":"CIT0025","first-page":"3518 \u2014 3523","volume":"91","author":"Zent C.S.","year":"1998","journal-title":"\"Oligoclonal protein bands and Ig isotype switching in multiple myeloma treated with high-dose therapy and hematopoietic cell transplantation\", Blood"},{"key":"CIT0026","first-page":"748","volume":"104","author":"Guikema J.E.","year":"1999","journal-title":"\"Multiple myeloma related cells in patients undergoing autologous peripheral blood stem cell transplantation\", British Journal of Haematology"},{"key":"CIT0027","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1702194"},{"key":"CIT0028","first-page":"1091","volume":"178","author":"Corradini P.","year":"1993","journal-title":"\"Evidence for a bone marrow B cell transcribing malignant plasma cell VDJ joined to C mu sequence in immunoglobulin (IgG)- and IgA-secreting multiple myelomas\", Journal of Experimental Med-icine"},{"key":"CIT0029","first-page":"1023","volume":"178","author":"Billadeau D.","year":"1993","journal-title":"\"The bone marrow of multiple myeloma patients contains B cell populations at different stages of differentiation that are clonally related to the malignant plasma cell\", Journal of Experimental Medicine"},{"key":"CIT0030","first-page":"94, 1070\u2014 1076","author":"Sahota S.S.","year":"1999","journal-title":"Blood"},{"key":"CIT0031","first-page":"2791 \u2014 2799","volume":"98","author":"Reiman T.","year":"2001","journal-title":"evidence for isotype switching within the myeloma clone\", Blood"},{"key":"CIT0032","first-page":"54 \u2014 61","volume":"119","author":"Guikema J.E.","year":"2002","journal-title":"\"Myeloma clonotypic B cells are hampered in their ability to undergo B- cell differentiation in vitro\", British Journal of Haematology"},{"key":"CIT0033","first-page":"1127 \u2014 1132","volume":"15","author":"Bakkus M.H.","year":"2001","journal-title":"evidence that myeloma IgM and IgA expressing subclones can originate from the IgG expressing tumour\", Leukemia"},{"key":"CIT0034","first-page":"791 \u2014 799","volume":"28","author":"Bloem AC.","year":"1988","journal-title":"\"Phenotypical and functional characterization of the idiotype-positive blood B cells in multiple myeloma\", Scandinavian Journal of Immunology"},{"key":"CIT0035","first-page":"792","volume":"150","author":"Kubagawa H.","year":"1979","journal-title":"Use of individually specific (idiotype) anti-bodies to trace the oncogenic event to its earliest point of expression in B-cell differentiation\", Journal of Experimental Medicine"},{"key":"CIT0036","first-page":"2642","volume":"78","author":"Osterborg A.","year":"1991","journal-title":"\"Establishment of idiotype bearing B-lymphocyte clones from a patient with monoclonal gammopathy\", Blood"},{"key":"CIT0037","first-page":"724","volume":"83","author":"Pilarski L.M.","year":"1994","journal-title":"\"Circulating monoclonal B cells expressing P glycoprotein may be a reservoir of multidrug-resistant disease in multiple myeloma\", Blood"},{"key":"CIT0038","first-page":"3751","volume":"90","author":"Pilarski L.M.","year":"1997","journal-title":"\"Deficient drug transporter function of bone marrow-localized and leukemic plasma cells in multiple myeloma\", Blood"},{"key":"CIT0039","first-page":"2844","volume":"92","author":"Szczepek A.J.","year":"1998","journal-title":"\"A high frequency of circulating B cells share clonotypic Ig heavy-chain VDJ rearrangements with auto-logous bone marrow plasma cells in multiple myeloma, as measured by single-cell and in situ reverse transcriptase- poly-merase chain reaction\", Blood"},{"issue":"5","key":"CIT0040","first-page":"\u20136","volume":"87","author":"Chen B.J.","year":"1905","journal-title":"Blood"},{"key":"CIT0041","doi-asserted-by":"crossref","first-page":"1824 \u2014","DOI":"10.1182\/blood.V89.5.1824","volume":"89","author":"Szczepek A.J.","year":"1833","journal-title":"Blood"},{"key":"CIT0042","first-page":"585","volume":"6","author":"Pilarski L.M.","year":"2000","journal-title":"\"In multiple myeloma, circulating hyperdiploid B cells have clonotypic immunoglobulin heavy chain rearrangements and may mediate spread of disease\", Clinical Cancer Research"},{"key":"CIT0043","first-page":"1076 \u2014 1081","volume":"29","author":"Szczepek A.J.","year":"2001","journal-title":"potential for autocrine and paracrine net-works\", Experimental Hematology"},{"key":"CIT0044","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1996.d01-1677.x"},{"key":"CIT0045","first-page":"117, 642 \u2014 645","author":"Voena C.","year":"2002","journal-title":"British Journal of Haematology"},{"key":"CIT0046","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1999.01770.x"},{"key":"CIT0047","first-page":"340 \u2014 345","volume":"90","author":"Kay N.E.","year":"1997","journal-title":"analysis and relationship to circulating clonal cells and clinical parameters in a cohort of patients entered on the Eastern Cooperative Oncology Group phase III E9486 clinical trial\", Blood"},{"key":"CIT0048","first-page":"23","volume":"98","author":"Kay N.E.","year":"2001","journal-title":"results of an Eastern Cooperative Oncology Group phase 3 trial for newly diagnosed multiple myeloma patients\", Blood"},{"key":"CIT0049","first-page":"106, 40 \u2014 46","author":"Davies FE.","year":"1999","journal-title":"British Journal of Haematology"},{"key":"CIT0050","first-page":"1034 \u2014 1039","volume":"11","author":"Zandecki M.","year":"1997","journal-title":"chromosome changes are the rule within circulating plasma cells but not within B lymphocytes\", Leukemia"},{"key":"CIT0051","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2002.03529.x"},{"key":"CIT0052","first-page":"85, 436 \u2014 447","author":"Bergsagel P.L.","year":"1995","journal-title":"Blood"},{"key":"CIT0053","first-page":"1019 \u2014 1027","volume":"23","author":"Kiel K.","year":"1999","journal-title":"\"Analysis of circulating tumor cells in patients with multiple myeloma during the course of high-dose therapy with peripheral blood stem cell transplanta-tion\", Bone Marrow Transplantation"},{"key":"CIT0054","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1999.01548.x"},{"key":"CIT0055","first-page":"42, 1359 \u2014 1366","author":"Rasmussen T","year":"2001","journal-title":"Leukemia and Lymphoma"},{"key":"CIT0056","first-page":"86, 390\u2014 397","author":"Schiller G.","year":"1995","journal-title":"Blood"},{"key":"CIT0057","first-page":"387 \u2014 395","volume":"41","author":"Mitterer M.","year":"2001","journal-title":"\"Peripheral blood monoclonal B-cells predict the event free survival in multiple myeloma\", Leukemia and Lymphoma"},{"key":"CIT0058","first-page":"1056\u2014 1065","volume":"95","author":"Pilarski L.M.","year":"2000","journal-title":"engraftment and self-renewal of primary human myeloma in the bone marrow of NOD SCID mice\", Blood"},{"key":"CIT0059","first-page":"94, 318\u2014 323","author":"Wijdenes J.","year":"1996","journal-title":"British Journal of Haematology"},{"key":"CIT0060","first-page":"2679 \u2014 2688","volume":"91","author":"Dhodapkar MN.","year":"1998","journal-title":"control of tumor cell survival, growth, and bone cell differentiation\", Blood"},{"key":"CIT0061","first-page":"388\u2014 392","volume":"95","author":"Seidel C.","year":"2000","journal-title":"a new independent prognostic marker in multiple myeloma\", Blood"},{"key":"CIT0062","first-page":"97, 56 \u2014 64","author":"Schneider U.","year":"1997","journal-title":"British Journal of Haematology"},{"key":"CIT0063","first-page":"92, 3887 \u2014 3897","author":"Mahmoud M.S.","year":"1998","journal-title":"Blood"},{"key":"CIT0064","doi-asserted-by":"publisher","DOI":"10.3109\/10428190009053538"},{"key":"CIT0065","doi-asserted-by":"crossref","first-page":"3880","DOI":"10.1182\/blood.V96.12.3880","author":"Rawstron AC.","year":"2000","journal-title":"Blood"},{"key":"CIT0066","doi-asserted-by":"publisher","DOI":"10.1016\/S0301-472X(00)00625-1"},{"key":"CIT0067","first-page":"1243 \u2014 1251","volume":"76","author":"Caligaris-Cappio F.","year":"1985","journal-title":"\"Identification of malignant plasma cell precursors in the bone marrow of multiple myeloma\", Journal of Clinical Investigation"},{"key":"CIT0068","first-page":"1948 \u2014","volume":"9","author":"Cao J.","year":"1953","journal-title":"Leukemia"},{"key":"CIT0069","first-page":"377 \u2014 382","volume":"76","author":"Van Camp B.","year":"1990","journal-title":"CD56 (NKH-1; Leu-19)\", Blood"},{"key":"CIT0070","first-page":"117, 882 \u2014885","author":"Sahara N.","year":"2002","journal-title":"British Journal of Haematology"},{"key":"CIT0071","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1995.tb05175.x"},{"key":"CIT0072","first-page":"104, 138 \u2014 143","author":"Rawstron A.","year":"1999","journal-title":"British Journal of Haematology"},{"key":"CIT0073","first-page":"3647 \u2014 3653","volume":"55","author":"Pellat-Deceunynck C.","year":"1995","journal-title":"significant changes in expression related to malignancy, tumor spreading, and immortalization\", Cancer Research"},{"key":"CIT0074","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401211"},{"key":"CIT0075","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2002.03258.x"},{"key":"CIT0076","first-page":"2658 \u2014 2663","volume":"81","author":"Harada H.","year":"1993","journal-title":"\"Phenotypic difference of normal plasma cells from mature myeloma cells\", Blood"},{"key":"CIT0077","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.1182\/blood.V94.10.3551.422k08_3551_3558","author":"Mahmoud M.S.","year":"1999","journal-title":"Blood"},{"key":"CIT0078","author":"San Miguel J.F.","year":"2002","journal-title":"Blood"},{"key":"CIT0079","first-page":"3095","volume":"100","author":"Rawstron A.C.","year":"2002","journal-title":"the relationship between normal and neoplastic plasma cells predicts outcome after transplantation\", Blood"},{"key":"CIT0080","doi-asserted-by":"publisher","DOI":"10.1002\/1096-8652(200008)64:4<311::AID-AJH13>3.0.CO;2-U"},{"key":"CIT0081","doi-asserted-by":"publisher","DOI":"10.1016\/S0145-2126(01)00075-3"},{"key":"CIT0082","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1182\/blood.V88.8.3101.bloodjournal8883101","author":"Stauder R.","year":"1996","journal-title":"Blood"},{"key":"CIT0083","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401179"},{"key":"CIT0084","first-page":"16, 135 \u2014 143","author":"van Driel M.","year":"2002","journal-title":"Leukemia"},{"key":"CIT0085","first-page":"185","volume":"77","author":"San Miguel J.F.","year":"1991","journal-title":"Castellano-Leones (Spain) Coopera-tive Group for the Study of Monoclonal Gammopathies\", British Journal of Haematology"},{"key":"CIT0086","first-page":"97 \u2014 106","volume":"26","author":"Treon S.P.","year":"1999","journal-title":"\"Treatment of plasma cell dyscrasias by antibody-mediated immunotherapy\", Seminars in Oncology"},{"key":"CIT0087","first-page":"72","volume":"25","author":"Treon S.P.","year":"2002","journal-title":"biologic considerations and therapeutic applications\", Journal of Immunotherapy"},{"key":"CIT0088","first-page":"84, 2457 \u2014 2466","author":"Maloney D.G.","year":"1994","journal-title":"Blood"},{"key":"CIT0089","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1200\/JCO.1998.16.8.2825","author":"McLaughlin P","year":"1998","journal-title":"Journal of Clinical Oncology"},{"key":"CIT0090","first-page":"1927 \u2014 1932","volume":"92","author":"Coiffier B.","year":"1998","journal-title":"a multicenter phase II study\", Blood"},{"key":"CIT0091","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1182\/blood.V95.3.1039.003k02_1039_1046","author":"Teoh G.","year":"2000","journal-title":"Blood"},{"key":"CIT0092","doi-asserted-by":"crossref","first-page":"1903\u2013","DOI":"10.1182\/blood.V85.7.1903.bloodjournal8571903","volume":"85","author":"Urashima M.","year":"1912","journal-title":"Blood"},{"key":"CIT0093","first-page":"152, 117 \u2014 128","author":"Westendorf J.J.","year":"1994","journal-title":"Journal of Immunology"},{"key":"CIT0094","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1996.tb08993.x"},{"key":"CIT0095","author":"Ocqueteau M.","year":"1998","journal-title":"American Journal of Pathology"},{"key":"CIT0096","first-page":"457 \u2014464","volume":"20","author":"Lemoli R.M.","year":"1996","journal-title":"\"C-kit ligand (SCF) in human multiple myeloma cells\", Leukemia and Lymphoma"},{"key":"CIT0097","doi-asserted-by":"publisher","DOI":"10.1172\/JCI116761"},{"key":"CIT0098","first-page":"2597 \u2014 2603","volume":"84","author":"Pellat-Deceunynck C.","year":"1994","journal-title":"a comparative study with normal plasma cells\", Blood"},{"key":"CIT0099","first-page":"1521","author":"Robillard N.","year":"1998","journal-title":"Clinical Cancer Research"},{"key":"CIT0100","first-page":"187","volume":"98","author":"Shapiro VS.","year":"2001","journal-title":"implications for multiple myeloma progression\", Blood"},{"key":"CIT0101","first-page":"36","volume":"121","author":"Guikema J.E.","year":"2003","journal-title":"low CD27 expression in patients with high-risk disease\", British Journal of Haematology"},{"key":"CIT0102","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2003.04069.x"},{"key":"CIT0103","first-page":"1745","volume":"99","author":"Zhan F.","year":"2002","journal-title":"\"Global gene expression profiling of multiple myeloma, monoclonal gammopathy of undetermined significance, and normal bone marrow plasma cells\", Blood"},{"key":"CIT0104","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.12.6346"},{"key":"CIT0105","first-page":"3854\u2014 3859","volume":"55","author":"Drach J.","year":"1995","journal-title":"high incidence of chromosomal aneuploidy as detected by interphase fluorescence in situ hybridization\", Cancer Research"},{"key":"CIT0106","first-page":"2109 \u2014 2114","volume":"9","author":"Flactif M.","year":"1995","journal-title":"\"Interphase fluorescence in situ hybridization (FISH) as a powerful tool for the detection of aneuploidy in multiple myeloma\", Leukemia"},{"key":"CIT0107","first-page":"840","volume":"15","author":"Gutierrez N.C.","year":"2001","journal-title":"\"Differences in genetic changes between multiple myeloma and plasma cell leukemia demonstrated by comparative genomic hybridization\", Leukemia"},{"key":"CIT0108","first-page":"3007 \u2014 3010","volume":"91","author":"Cigudosa J.C.","year":"1998","journal-title":"\"Characterization of nonrandom chromosomal gains and losses in multiple myeloma by compara-tive genomic hybridization\", Blood"},{"key":"CIT0109","first-page":"217","volume":"94","author":"Zandecki M.","year":"1996","journal-title":"almost all patients are cytogenetically abnormal\", British Journal of Haematology"},{"key":"CIT0110","doi-asserted-by":"crossref","first-page":"1925\u2013","DOI":"10.1182\/blood.V95.6.1925","volume":"95","author":"Zojer N.","year":"1930","journal-title":"Blood"},{"key":"CIT0111","first-page":"715","volume":"62","author":"Fonseca R.","year":"2002","journal-title":"an eastern cooperative oncology group study\", Cancer Research"},{"key":"CIT0112","first-page":"97, 1566\u2014 1571","author":"Facon T","year":"2001","journal-title":"Blood"},{"key":"CIT0113","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2003.03948.x"},{"key":"CIT0114","first-page":"96, 1505 \u2014 1511","author":"Shaughnessy J.","year":"2000","journal-title":"Blood"},{"key":"CIT0115","first-page":"36, 99 \u2014 106","author":"Elnenaei M.O.","year":"2003","journal-title":"Genes Chromosomes Cancer"},{"key":"CIT0116","first-page":"643","volume":"323","author":"Friend S.H.","year":"1986","journal-title":"\"A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma\", Nature"},{"key":"CIT0117","first-page":"664","volume":"91","author":"Juge-Morineau N.","year":"1995","journal-title":"\"High incidence of deletions but infrequent inactivation of the retinoblastoma gene in human myeloma cells\", British Journal of Haematology"},{"key":"CIT0118","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1182\/blood.V88.6.2219.bloodjournal8862219","author":"Urashima M.","year":"1996","journal-title":"Blood"},{"key":"CIT0119","first-page":"2583","volume":"94","author":"Avet-Loiseau H.","year":"1999","journal-title":"Intergroupe Francophone du Myelome\", Blood"},{"key":"CIT0120","first-page":"118, 545 \u2014 549","author":"Bernasconi P.","year":"2002","journal-title":"British Journal of Haematology"},{"key":"CIT0121","first-page":"5611","volume":"20","author":"Bergsagel P.L.","year":"2001","journal-title":"\"Chromosome transloca-tions in multiple myeloma\", Oncogene"},{"key":"CIT0122","doi-asserted-by":"publisher","DOI":"10.1038\/nrc746"},{"key":"CIT0123","first-page":"75","volume":"20","author":"Fenton J.A.","year":"2002","journal-title":"\"Isotype class switching and the pathogenesis of multiple myeloma\", Hematological Oncology"},{"key":"CIT0124","first-page":"5640","author":"Avet-Loiseau H.","year":"1998","journal-title":"Cancer Research"},{"key":"CIT0125","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1182\/blood.V92.9.3025","author":"Chesi M.","year":"1998","journal-title":"Blood"},{"key":"CIT0126","doi-asserted-by":"crossref","first-page":"4062","DOI":"10.1182\/blood.V90.10.4062","author":"Richelda R.","year":"1997","journal-title":"Blood"},{"key":"CIT0127","first-page":"98, 217 \u2014 223","author":"Shaughnessy J","year":"2001","journal-title":"Blood"},{"key":"CIT0128","doi-asserted-by":"publisher","DOI":"10.1038\/ng1097-226"},{"key":"CIT0129","first-page":"283","volume":"224","author":"Bergsagel P.L.","year":"1997","journal-title":"a nearly universal event that rarely involves c-myc\", Current Topics in Microbiology and Immunology"},{"key":"CIT0130","first-page":"277","volume":"224","author":"Kuehl W.M.","year":"1997","journal-title":"\"Dysregulation of c-myc in multiple myeloma\", Current Topics in Microbiology and Immunology"},{"key":"CIT0131","doi-asserted-by":"crossref","first-page":"4457","DOI":"10.1182\/blood.V91.12.4457","author":"Chesi M.","year":"1998","journal-title":"Blood"},{"key":"CIT0132","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.2001.tb01142.x"},{"key":"CIT0133","first-page":"1743\u2013","volume":"92","author":"Rao PH.","year":"1748","journal-title":"Blood"},{"key":"CIT0134","first-page":"100, 1579\u2014 1583","author":"Moreau P.","year":"2002","journal-title":"Blood"},{"key":"CIT0135","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.10.3735"},{"key":"CIT0136","first-page":"98, 2266\u2014 2268","author":"Hayman SR.","year":"2001","journal-title":"Blood"},{"key":"CIT0137","first-page":"503\u2014 511","volume":"403","author":"Alizadeh A.A.","year":"2000","journal-title":"\"Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling\", Nature"},{"key":"CIT0138","first-page":"1113","volume":"100","author":"Tarte K.","year":"2002","journal-title":"a normal counterpart of malignant plasmablasts\", Blood"},{"key":"CIT0139","first-page":"6848 \u2014 6857","volume":"21","author":"De Vos J.","year":"2002","journal-title":"\"Comparison of gene expression profiling between malignant and normal plasma cells with oligonucleotide arrays\", Oncogene"},{"key":"CIT0140","first-page":"101, 1128 \u2014 114","author":"Zhan F.","year":"2003","journal-title":"Blood"}],"container-title":["Leukemia &amp; Lymphoma"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10428190310001593201","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,31]],"date-time":"2020-03-31T15:48:24Z","timestamp":1585669704000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.1080\/10428190310001593201"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,5]]},"references-count":140,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2009,8,3]]},"published-print":{"date-parts":[[2004,5]]}},"alternative-id":["10.1080\/10428190310001593201"],"URL":"https:\/\/doi.org\/10.1080\/10428190310001593201","relation":{},"ISSN":["1042-8194","1029-2403"],"issn-type":[{"value":"1042-8194","type":"print"},{"value":"1029-2403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,5]]}}}